NADAC acquisition cost data for ELURYNG VAGINAL RING. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 65162046932 | $79.83 | 2022-12-21 | Rx |
| 65162046935 | $79.83 | 2022-12-21 | Rx |
| 65162046932 | $79.83 | 2022-12-21 | Rx |
| 65162046935 | $79.83 | 2022-12-21 | Rx |
Generic: Etonogestrel/Ethinyl Estradiol | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.8K | 22 | 22 | $137.78 |
| 2020 | $456.0K | 1,989 | 759 | $124.01 |
| 2021 | $623.6K | 2,812 | 979 | $110.41 |
| 2022 | $709.9K | 3,349 | 1,219 | $103.74 |
| 2023 | $783.9K | 3,576 | 1,245 | $99.84 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $79.9K | 354 | 115 |
| Ohio | $64.2K | 308 | 92 |
| Pennsylvania | $58.5K | 224 | 90 |
| Michigan | $47.8K | 210 | 75 |
| California | $42.4K | 205 | 89 |
| Texas | $33.2K | 153 | 53 |
| Wisconsin | $32.5K | 136 | 52 |
| Illinois | $29.2K | 133 | 48 |
| Missouri | $25.9K | 143 | 42 |
| New Jersey | $25.6K | 126 | 36 |
| Minnesota | $24.3K | 82 | 30 |
| Washington | $23.2K | 97 | 44 |
| Massachusetts | $21.0K | 91 | 32 |
| North Carolina | $20.7K | 96 | 33 |
| Tennessee | $18.5K | 117 | 29 |
| Maryland | $17.9K | 73 | 24 |
| Florida | $17.8K | 87 | 30 |
| Indiana | $13.6K | 64 | 23 |
| Oklahoma | $13.3K | 44 | 17 |
| Maine | $12.1K | 56 | 19 |
| Kansas | $11.2K | 38 | 15 |
| Virginia | $11.1K | 55 | 22 |
| Colorado | $11.0K | 46 | 17 |
| Oregon | $10.6K | 42 | 21 |
| Utah | $8.5K | 43 | 15 |
| Iowa | $8.1K | 31 | 12 |
| Alabama | $7.9K | 43 | 15 |
| Arkansas | $7.7K | 58 | N/A |
| New Hampshire | $7.6K | 34 | 14 |
| Louisiana | $7.5K | 42 | 16 |
| Connecticut | $7.4K | 28 | 14 |
| Vermont | $6.3K | 27 | N/A |
| West Virginia | $6.3K | 30 | N/A |
| Kentucky | $6.2K | 36 | 12 |
| Georgia | $5.4K | 38 | 13 |
| Alaska | $5.0K | 23 | N/A |
| South Carolina | $4.2K | 16 | N/A |
| Idaho | $3.8K | 15 | N/A |
| Mississippi | $3.7K | 25 | N/A |
| Rhode Island | $3.4K | 11 | N/A |
| Arizona | $2.8K | 21 | N/A |
| Wyoming | $2.4K | 12 | N/A |
| Delaware | $2.1K | 13 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.